USA - NYSE:BUD - US03524A1088 - ADR
ChartMill assigns a Buy % Consensus number of 83% to BUD. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-12 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2025-01-08 | TD Cowen | Maintains | Hold -> Hold |
| 2024-10-08 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-10-01 | Citigroup | Upgrade | Neutral -> Buy |
| 2024-09-10 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-07-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-03-05 | TD Cowen | Maintains | Outperform -> Outperform |
| 2024-01-12 | Exane BNP Paribas | Downgrade | Outperform -> Neutral |
| 2024-01-10 | Jefferies | Upgrade | Hold -> Buy |
| 2023-11-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-09-29 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-07-20 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2023-06-22 | Deutsche Bank | Upgrade | Hold -> Buy |
| 2023-06-08 | Evercore ISI Group | Maintains | Outperform |
| 2021-11-19 | Redburn Partners | Upgrade | Neutral -> Buy |
| 2021-09-30 | Argus Research | Downgrade | Buy -> Hold |
| 2021-09-02 | JP Morgan | Downgrade | Neutral -> Underweight |
32 analysts have analysed BUD and the average price target is 79.4 USD. This implies a price increase of 30.38% is expected in the next year compared to the current price of 60.9.
The consensus rating for ANHEUSER-BUSCH INBEV-SPN ADR (BUD) is 83.125 / 100 . This indicates that analysts generally have a positive outlook on the stock.